Core Viewpoint - JianKai Technology (688356.SH) reported significant growth in its 2025 annual performance, driven by strong overseas business expansion [1] Financial Performance - The company achieved total operating revenue of 316.085 million yuan, representing a year-on-year increase of 39.19% [1] - Net profit attributable to the parent company reached 63.3935 million yuan, marking a year-on-year growth of 112.46% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 49.4382 million yuan, reflecting a year-on-year increase of 153.79% [1] Business Growth Drivers - The growth in operating revenue and profit was primarily due to significant increases in overseas business [1] - Sales of new drug products from overseas customers continued to grow, leading to substantial revenue from related orders [1] - Orders from the company's largest overseas medical device customer increased significantly compared to the same period last year, contributing to steady growth in overseas medical device sales revenue [1]
键凯科技(688356.SH):2025年净利润6339.35万元,同比增长112.46%